Profile
Michael F.
Snape is the founder of AMO Pharma Ltd.
(founded in 2015) and holds the title of Chief Scientific Officer.
Dr. Snape is also the founder of Neuropharm Group Plc.
Michael F. Snape active positions
| Companies | Position | Start |
|---|---|---|
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Founder | 2014-12-31 |
Former positions of Michael F. Snape
| Companies | Position | End |
|---|---|---|
Neuropharm Group Plc
 Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Neuropharm Group Plc develops and manufactures speciality pharmaceuticals. It develops medicines for the treatment and management of neurodevelopmental disorders. The company was founded by Dr. Michael Snape and is headquartered in Leatherhead, the United Kingdom. | Founder | 2010-07-11 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Neuropharm Group Plc develops and manufactures speciality pharmaceuticals. It develops medicines for the treatment and management of neurodevelopmental disorders. The company was founded by Dr. Michael Snape and is headquartered in Leatherhead, the United Kingdom. | Health Technology |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Michael F. Snape
